Why the study?
Does intrapericardial mitomycin C control malignant pericardial effusion in a patient with gastric cancer?
Does intrapericardial mitomycin C control malignant pericardial effusion in a patient with gastric cancer?
Answers are grounded in this paper and cite their sources.
Intrapericardial instillation of mitomycin C following pericardiocentesis may be an effective and safe management strategy for malignant pericardial effusion.
In a 57-year-old man with recurrent gastric cancer, cardiac tamponade due to malignant pericardial effusion developed. Echocardiographically guided pericardiocentesis followed by an intrapericardial instillation of mitomycin C provided a complete control of the pericardial effusion, and no adverse effects were observed with this procedure. An intrapericardial instillation with effective anticancer agents is therefore considered to be useful for the management of malignant pericardial effusion.
No takes yet. Share an insight, caveat, or question.
Kohnoe et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: